{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:54:06Z","timestamp":1792814046001,"version":"4.5.0"},"reference-count":32,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,1]]},"abstract":"<jats:p>Here we describe the case of a patient followed from birth because of a positive family history for apparent mineralocorticoid excess (AME) in an older brother. The patient, a girl, had normal serum electrolyte and blood pressure measurements in the first months after birth. Not until the age of 11 months did she develop anorexia and failure to thrive in combination with hypertension, hypokalemia, and metabolic alkalosis, which are consistent with the diagnosis of AME. This diagnosis was confirmed by mutation analysis of the HSD11B2 gene (C1228T). Treatment with amiloride and furosemide electrolyte disturbances normalized her blood pressure. At the age of 19 years she unexpectedly suffered a stroke. Additional investigations revealed no accepted risk factor for stroke. We discuss the possible underlying mechanisms for the delayed manifestation of hypertension and electrolyte disturbances in AME, propose an additional explanation for the stroke in this patient, and advise treatment with a mineralocorticoid receptor antagonist to reduce stroke risk in patients with AME.<\/jats:p>","DOI":"10.1542\/peds.2010-1928","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T02:29:10Z","timestamp":1304389750000},"page":"e1610-e1614","source":"Crossref","is-referenced-by-count":20,"title":["Apparent Mineralocorticoid Excess: Time of Manifestation and Complications Despite Treatment"],"prefix":"10.1542","volume":"127","author":[{"given":"No\u00ebl B. B.","family":"Knops","sequence":"first","affiliation":[{"name":"Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A.","family":"Monnens","sequence":"additional","affiliation":[{"name":"Department of Physiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques W.","family":"Lenders","sequence":"additional","affiliation":[{"name":"Division of Vascular Medicine, Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands; and"},{"name":"Department of Internal Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena N.","family":"Levtchenko","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"issue":"1","key":"2021120900212560000_B1","first-page":"135","article-title":"11 \u03b2-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess","volume":"18","author":"White","year":"1997","journal-title":"Endocr Rev"},{"issue":"9161","key":"2021120900212560000_B2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(98)06102-9","article-title":"Mineralocorticoid hypertension","volume":"353","author":"Stewart","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"2021120900212560000_B3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000179490","article-title":"Low-renin, low-aldosterone hypertension and abnormal cortisol metabolism in a 19-month-old child","volume":"16","author":"Fiselier","year":"1982","journal-title":"Horm Res"},{"issue":"11","key":"2021120900212560000_B4","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1681\/ASN.2006060570","article-title":"Apparent mineralocorticoid excess: report of six new cases and extensive personal experience","volume":"17","author":"Morineau","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"4 pt 1","key":"2021120900212560000_B5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.HYP.34.4.638","article-title":"Mutants of 11\u03b2-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess","volume":"34","author":"Nunez","year":"1999","journal-title":"Hypertension"},{"issue":"12","key":"2021120900212560000_B6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/adc.58.12.1018","article-title":"Fatal, low renin hypertension associated with a disturbance of cortisol metabolism","volume":"58","author":"Honour","year":"1983","journal-title":"Arch Dis Child"},{"issue":"2","key":"2021120900212560000_B7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.1995.tb01923.x","article-title":"Mineralocorticoid hypertension and congenital deficiency of 11 \u03b2-hydroxysteroid dehydrogenase in a family with the syndrome of \u201capparent\u201d mineralocorticoid excess","volume":"43","author":"Milford","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2021120900212560000_B8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF00442742","article-title":"The renin-angiotensin-aldosterone system in infancy and childhood in basal conditions and after stimulation","volume":"143","author":"Fiselier","year":"1984","journal-title":"Eur J Pediatr"},{"issue":"11","key":"2021120900212560000_B9","first-page":"1385","article-title":"Renal parameters during infancy","volume":"29","author":"Mehta","year":"1992","journal-title":"Indian Pediatr"},{"issue":"9","key":"2021120900212560000_B10","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1210\/en.2008-1498","article-title":"Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates","volume":"150","author":"Martinerie","year":"2009","journal-title":"Endocrinology"},{"issue":"5","key":"2021120900212560000_B11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1203\/00006450-200011000-00024","article-title":"Evidence for change of 11\u03b2-hydroxysteroid dehydrogenase activity during infancy and childhood","volume":"48","author":"D\u00f6tsch","year":"2000","journal-title":"Pediatr Res"},{"issue":"7","key":"2021120900212560000_B12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00467-007-0432-3","article-title":"Potassium transport in the maturing kidney","volume":"22","author":"Gurkan","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2021120900212560000_B13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.avsg.2008.04.005","article-title":"Ten-year epidemiological review of in-hospital patients with Marfan syndrome","volume":"22","author":"Chan","year":"2008","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"2021120900212560000_B14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/hs0302.103816","article-title":"Neurovascular complications of Marfan syndrome: a retrospective, hospital-based study","volume":"33","author":"Wityk","year":"2002","journal-title":"Stroke"},{"issue":"4","key":"2021120900212560000_B15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0039-128X(96)00012-8","article-title":"Apparent mineralocorticoid excess: type I and type II","volume":"61","author":"Mantero","year":"1996","journal-title":"Steroids"},{"issue":"7","key":"2021120900212560000_B16","first-page":"2244","article-title":"Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess","volume":"83","author":"Dave-Sharma","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"1 pt 2","key":"2021120900212560000_B17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/01.HYP.31.1.459","article-title":"Localization of 2 11\u03b2-OH steroid dehydrogenase isoforms in aortic endothelial cells","volume":"31","author":"Brem","year":"1998","journal-title":"Hypertension"},{"issue":"5","key":"2021120900212560000_B18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.HYP.33.5.1179","article-title":"11\u03b2-Hydroxysteroid dehydrogenase in cultured human vascular cells: possible role in the development of hypertension","volume":"33","author":"Hatakeyama","year":"1999","journal-title":"Hypertension"},{"issue":"2","key":"2021120900212560000_B19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0006-8993(91)91612-5","article-title":"Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus","volume":"561","author":"Seckl","year":"1991","journal-title":"Brain Res"},{"issue":"2","key":"2021120900212560000_B20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3940(00)01325-2","article-title":"Expression of mineralocorticoid and glucocorticoid receptor mRNA in the human hippocampus","volume":"290","author":"Watzka","year":"2000","journal-title":"Neurosci Lett"},{"issue":"23","key":"2021120900212560000_B21","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1161\/hc4801.100077","article-title":"Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11\u03b2-hydroxysteroid dehydrogenase","volume":"104","author":"Hadoke","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"2021120900212560000_B22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.HYP.0000196945.73586.0d","article-title":"Mineralocorticoid receptor activation causes cerebral vessel remodeling and exacerbates the damage caused by cerebral ischemia","volume":"47","author":"Dorrance","year":"2006","journal-title":"Hypertension"},{"issue":"2","key":"2021120900212560000_B23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1210\/en.2008-0808","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemia","volume":"150","author":"Osmond","year":"2009","journal-title":"Endocrinology"},{"issue":"3","key":"2021120900212560000_B24","doi-asserted-by":"crossref","first-page":"R944","DOI":"10.1152\/ajpregu.2001.281.3.R944","article-title":"Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats","volume":"281","author":"Dorrance","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"2021120900212560000_B25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.mvr.2006.12.001","article-title":"Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats","volume":"73","author":"Rigsby","year":"2007","journal-title":"Microvasc Res"},{"issue":"3","key":"2021120900212560000_B26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/HYPERTENSIONAHA.109.134130","article-title":"Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats","volume":"54","author":"Tada","year":"2009","journal-title":"Hypertension"},{"issue":"4","key":"2021120900212560000_B27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/HJH.0b013e32832810ed","article-title":"Aldosterone-receptor antagonism in hypertension","volume":"27","author":"Jansen","year":"2009","journal-title":"J Hypertens"},{"issue":"2","key":"2021120900212560000_B28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jpeds.2010.02.042","article-title":"The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: a randomized, double-blind, dose-response study","volume":"157","author":"Li","year":"2010","journal-title":"J Pediatr"},{"issue":"3","key":"2021120900212560000_B29","first-page":"1247","article-title":"A mutation in the cofactor-binding domain of 11\u03b2-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension","volume":"86","author":"Odermatt","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"2021120900212560000_B30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2003.10.019","article-title":"Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population","volume":"217","author":"Quinkler","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2021120900212560000_B31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2265.1984.tb01388.x","article-title":"Apparent mineralocorticoid excess and deficient 11 \u03b2-oxidation of cortisol in a young female","volume":"21","author":"Harinck","year":"1984","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2021120900212560000_B32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jcem-63-3-550","article-title":"The syndrome of apparent mineralocorticoid excess: its association with 11 \u03b2-dehydrogenase and 5 \u03b2-reductase deficiency and some consequences for corticosteroid metabolism","volume":"63","author":"Monder","year":"1986","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/6\/e1610\/846585\/zpe006110e1610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/6\/e1610\/846585\/zpe006110e1610.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T05:58:14Z","timestamp":1639029494000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/127\/6\/e1610\/30030\/Apparent-Mineralocorticoid-Excess-Time-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,1]]},"published-print":{"date-parts":[[2011,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-1928","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,1]]}}}